The association of baseline frailty and quality of life in prostate cancer(FRAQ-PC study)

The association of baseline frailty and quality of life in prostate cancer(FRAQ-PC study) - The association of baseline frailty and quality of life in prostate cancer(FRAQ-PC study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039867

Enrollment

400

Registered

2020-03-19

Start date

2017-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with prostate cancer who can evaluate frailty

Exclusion criteria

Exclusion criteria: Patients with prostate cancer who cannot evaluate frailty

Design outcomes

Primary

Measure	Time frame
Primary outcomes: the association of baseline frailty and quality of life.	—

Secondary

Measure	Time frame
Secondary outcomes: effect of frailty and QOL on overall survival in metastatic prostate cancer	—

Countries

Japan

Contacts

Public ContactShingo Hatakeyama

Dept. of Urology, Hirosaki University Graduate School of Medicine Urology

shingorilla2@gmail.com0172395091

Outcome results